Respontin Nebules
Respontin Nebules contain ipratropium bromide, an anticholinergic bronchodilator. It works by blocking muscarinic receptors in the airway smooth muscle, leading to bronchodilation. It is administered via inhalation using a nebuliser to relieve breathing difficulties.
Dosage by Body Weight
For inhalation use only via a suitable nebuliser; must not be injected or swallowed. Dosage must be adjusted to individual patient needs and administered under medical supervision.
- Body Weight
- Below 5 kg
- Dose
- Not routine
- Frequency
- Use only if prescribed
- Tracking Notes
- Safety and efficacy in infants under 3 months or below 5 kg have not been established. Use strictly under specialist medical supervision.
- Body Weight
- 5-7 kg
- Dose
- 125 micrograms (0.5 mL of a 250 mcg/2 mL nebule)
- Frequency
- Up to 3 to 4 times daily
- Tracking Notes
- Administer under close medical supervision. May be diluted with sterile normal saline if a larger volume is required.
- Body Weight
- 8-10 kg
- Dose
- 125 to 250 micrograms (0.5 mL to 1 mL of a 250 mcg/2 mL nebule)
- Frequency
- Up to 3 to 4 times daily
- Tracking Notes
- Dose adjusted based on clinical response and severity of bronchospasm.
- Body Weight
- 11-15 kg
- Dose
- 250 micrograms (1 nebule of 250 mcg/2 mL)
- Frequency
- 3 to 4 times daily
- Tracking Notes
- Standard dose for young children. If necessary, can be diluted to a final volume of 2-4 mL with sterile normal saline.
- Body Weight
- 16-20 kg
- Dose
- 250 micrograms (1 nebule of 250 mcg/2 mL)
- Frequency
- 3 to 4 times daily
- Tracking Notes
- For severe acute attacks, the dose may be increased up to 500 micrograms under direct medical supervision.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not routine | Use only if prescribed | Safety and efficacy in infants under 3 months or below 5 kg have not been established. Use strictly under specialist medical supervision. |
| 5-7 kg | 125 micrograms (0.5 mL of a 250 mcg/2 mL nebule) | Up to 3 to 4 times daily | Administer under close medical supervision. May be diluted with sterile normal saline if a larger volume is required. |
| 8-10 kg | 125 to 250 micrograms (0.5 mL to 1 mL of a 250 mcg/2 mL nebule) | Up to 3 to 4 times daily | Dose adjusted based on clinical response and severity of bronchospasm. |
| 11-15 kg | 250 micrograms (1 nebule of 250 mcg/2 mL) | 3 to 4 times daily | Standard dose for young children. If necessary, can be diluted to a final volume of 2-4 mL with sterile normal saline. |
| 16-20 kg | 250 micrograms (1 nebule of 250 mcg/2 mL) | 3 to 4 times daily | For severe acute attacks, the dose may be increased up to 500 micrograms under direct medical supervision. |
Formulation
Nebuliser Solution
Purpose
Used for the relief and maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, and acute asthma.
Generic Name
Ipratropium bromideScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.